atorvastatin vs bazedoxifene/conjugated estrogens
According to this portal's Publishing Organization, this page was last reviewed in August 2026 against our methodology. Figures and extracts on this site, including tables above 1,000 rows when the corpus is that large, are the publisher's responsibility.
Side-by-side comparison of atorvastatin and bazedoxifene/conjugated estrogens. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
minor Known Drug Interaction
7.3 Atorvastatin Concomitant administration of bazedoxifene (40 mg daily) and atorvastatin (20 mg, single-dose) to healthy postmenopausal women did not affect the pharmacokinetics of bazedoxifene, atorvastatin or its active metabolites.
Lipitor
Atorvastatin is a drug that lowers cholesterol and reduces the risk of heart problems and stroke. It belongs to a class of drugs called statins.
Duavee is a combination medicine containing estrogen and a drug that blocks estrogen in some parts of the body. It is used to treat menopause symptoms and prevent bone loss after menopause in women with a uterus.
Atorvastatin is used to lower bad cholesterol (LDL) and triglycerides in your blood. It can help prevent heart attacks, strokes, and the need for heart procedures in adults with heart disease or risk factors for it. It is also used in children 10 years and older with certain inherited cholesterol problems.
Duavee is used to treat moderate to severe hot flashes caused by menopause. It can also help prevent bone loss (osteoporosis) after menopause. You should only use Duavee if you are at significant risk of osteoporosis and other non-estrogen medications should be carefully considered. Use Duavee for the shortest time that works for you, based on your goals and risks.
Atorvastatin works by blocking a substance your body needs to make cholesterol. This helps to lower the amount of cholesterol in your blood. Lowering cholesterol can help prevent heart disease.
Duavee contains two medicines. Estrogen helps with menopause symptoms and bone loss. Bazedoxifene blocks estrogen's effects in the uterus, which lowers the risk of uterine cancer that can happen when taking estrogen alone.
- • Common cold symptoms
- • Joint pain
- • Diarrhea
- • Pain in arms or legs
- • Urinary tract infection
- • Muscle spasms
- • Nausea
- • Diarrhea
- • Upset stomach
- • Upper abdominal pain
- Fatigue 13,812
- Nausea 12,425
- Type 2 Diabetes Mellitus 11,244
- Diarrhoea 11,037
- Dyspnoea 11,029
No adverse event reports.
Atorvastatin can cause muscle problems, including muscle pain, tenderness, or weakness. In rare cases, this can lead to serious kidney damage. Tell your doctor right away if you have unexplained muscle pain, tenderness, or weakness, especially if you also have a fever or feel sick. Atorvastatin can also cause liver problems. Your doctor may do blood tests to check your liver before you start taking atorvastatin and while you are taking it.
Duavee has serious warnings. It can increase the risk of uterine cancer, stroke, blood clots, and dementia. Women taking Duavee should not take additional estrogens. Estrogen should not be used to prevent heart disease or dementia. Talk to your doctor about the risks and benefits of Duavee.
Atorvastatin can harm an unborn baby. You should not take atorvastatin if you are pregnant or planning to become pregnant. It is also not recommended to breastfeed while taking atorvastatin.
Do not take Duavee if you are pregnant. It can harm your unborn baby. Duavee is not for women who can get pregnant.
Also Compare, Nearby Drugs
Compare atorvastatin with
How to Read This atorvastatin vs bazedoxifene/conjugated estrogens Comparison
atorvastatin is classified in the HMG-CoA Reductase Inhibitor (Statin) drug class, while bazedoxifene/conjugated estrogens sits within the SERM / Estrogen Combination class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, atorvastatin has 59,547 submissions while bazedoxifene/conjugated estrogens has 0. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known minor interaction flagged in FDA labeling, attributed to studies show that these two medicines do not significantly change how the body processes each drug.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for atorvastatin or bazedoxifene/conjugated estrogens.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.